Skip to search formSkip to main contentSkip to account menu

Plasminogen Activator Inhibitor-1 Measurement

Known as: PAI1, Plasminogen Activator Inhibitor-1 
The determination of the amount of plasminogen activator inhibitor-1 present in a sample.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
BACKGROUND & AIMS Biliary atresia (BA) is a progressive fibroinflammatory disorder of infants involving the extrahepatic and… 
2013
2013
Idiopathic pulmonary fibrosis (IPF) is a progressive and life threatening disease with median survival of 2.5–3 years. The IPF… 
Highly Cited
2011
Highly Cited
2011
BackgroundVarious cytokines and inflammatory mediators are known to be involved in the pathogenesis of rheumatoid arthritis (RA… 
Highly Cited
2011
Highly Cited
2011
PURPOSE The bone morphogenic protein (BMP) antagonist gremlin is elevated in glaucomatous trabecular meshwork (TM) cells and… 
2011
2011
The infiltration of classically activated macrophages (M1) and alternatively activated macrophages (M2) in subcutaneous adipose… 
Highly Cited
2009
Highly Cited
2009
Metastatic growth and invasion by colon cancer cells in the liver requires the ability of the cancer cells to interact with the… 
Review
2008
Review
2008
OBJECTIVE Resistin increases insulin resistance (IR) in mice. However, the role of resistin in human disease remains… 
Highly Cited
2007
Highly Cited
2007
Background and Aim:  Overexpression of matrix metalloproteinase (MMP)‐1, ‐3, ‐7, ‐9, and plasminogen activator inhibitor‐1 (PAI‐1… 
Highly Cited
2005
Highly Cited
2005
ABSTRACT Testosterone induces a lethal outcome in otherwise self-healing blood-stage malaria caused by Plasmodium chabaudi. Here… 
Highly Cited
1989
Highly Cited
1989
The involvement of the erythropoietin (EPO), plasminogen activator inhibitor type I (PAI1), and multi-drug resistance (MDR2…